The Retinitis Pigmentosa industry is experiencing notable advancements driven by breakthroughs in gene therapy and retinal implant technologies. Increasing awareness and supportive government initiatives have amplified opportunities within this specialized market, setting the stage for sustainable business growth. Strategic investments and clinical

The Rett Syndrome market is witnessing significant momentum driven by advances in gene therapy and increasing awareness about rare neurodevelopmental disorders. Recent years have underscored a surge in research initiatives and investments aimed at addressing the complex pathology of Rett Syndrome, positioning the market for robust growth. This deta